zsp1603
Showing 1 - 1 of 1
Idiopathic Pulmonary Fibrosis (IPF) Trial in Shanghai (ZSP1603, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis (IPF)
- ZSP1603
- Placebo
-
Shanghai, Shanghai, ChinaShanghai Lung Hospital
Nov 3, 2021